TipRanks
Lumos Diagnostics Holdings Ltd. (AU:LDX)
ASX:LDX
Australian Market
Want to see AU:LDX full AI Analyst Report?

Lumos Diagnostics Holdings Ltd. (LDX) Stock Statistics & Valuation Metrics

28 Followers

Total Valuation

Lumos Diagnostics Holdings Ltd. has a market cap or net worth of AU$116.55M. The enterprise value is AU$85.46.
Market CapAU$116.55M
Enterprise ValueAU$85.46

Share Statistics

Lumos Diagnostics Holdings Ltd. has 971,221,860 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding971,221,860
Owned by Insiders―
Owned by Institutions―

Financial Efficiency

Lumos Diagnostics Holdings Ltd.’s return on equity (ROE) is -0.22 and return on invested capital (ROIC) is -45.56%.
Return on Equity (ROE)-0.22
Return on Assets (ROA)-0.12
Return on Invested Capital (ROIC)-45.56%
Return on Capital Employed (ROCE)-0.52
Revenue Per Employee464.88K
Profits Per Employee-174.51K
Employee Count29
Asset Turnover0.33
Inventory Turnover13.04

Valuation Ratios

The current PE Ratio of Lumos Diagnostics Holdings Ltd. is ―. Lumos Diagnostics Holdings Ltd.’s PEG ratio is 0.28.
PE Ratio―
PS Ratio4.38
PB Ratio2.59
Price to Fair Value2.59
Price to FCF-37.94
Price to Operating Cash Flow75.31
PEG Ratio0.28

Income Statement

In the last 12 months, Lumos Diagnostics Holdings Ltd. had revenue of 13.48M and earned -5.06M in profits. Earnings per share was >-0.01.
Revenue13.48M
Gross Profit-7.91M
Operating Income-14.44M
Pretax Income-5.57M
Net Income-5.06M
EBITDA-11.84M
Earnings Per Share (EPS)>-0.01

Cash Flow

In the last 12 months, operating cash flow was 970.13K and capital expenditures -2.49M, giving a free cash flow of -1.52M billion.
Operating Cash Flow970.13K
Free Cash Flow-1.52M
Free Cash Flow per Share>-0.01

Dividends & Yields

Lumos Diagnostics Holdings Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―

Stock Price Statistics

Beta2.12
52-Week Price Change-28.13%
50-Day Moving Average0.11
200-Day Moving Average0.18
Relative Strength Index (RSI)61.11
Average Volume (3m)1.03M

Important Dates

Lumos Diagnostics Holdings Ltd. upcoming earnings date is Mar 4, 2027, After Close (Confirmed).
Last Earnings DateAug 25, 2026
Next Earnings DateMar 4, 2027
Ex-Dividend Date―

Financial Position

Lumos Diagnostics Holdings Ltd. as a current ratio of 1.52, with Debt / Equity ratio of 25.98%
Current Ratio1.52
Quick Ratio1.40
Debt to Market Cap0.02
Net Debt to EBITDA0.80
Interest Coverage Ratio-6.90

Taxes

In the past 12 months, Lumos Diagnostics Holdings Ltd. has paid -510.98K in taxes.
Income Tax-510.98K
Effective Tax Rate0.09

Enterprise Valuation

Lumos Diagnostics Holdings Ltd. EV to EBITDA ratio is -4.19, with an EV/FCF ratio of -31.85.
EV to Sales3.68
EV to EBITDA-4.19
EV to Free Cash Flow-31.85
EV to Operating Cash Flow47.87

Balance Sheet

Lumos Diagnostics Holdings Ltd. has AU$15.42M in cash and marketable securities with AU$5.94M in debt, giving a net cash position of AU$9.48M billion.
Cash & Marketable SecuritiesAU$15.42M
Total DebtAU$5.94M
Net CashAU$9.48M
Net Cash Per Share<AU$0.01
Tangible Book Value Per ShareAU$0.01

Margins

Gross margin is -58.54%, with operating margin of -107.11%, and net profit margin of -37.54%.
Gross Margin-58.54%
Operating Margin-107.11%
Pretax Margin-41.33%
Net Profit Margin-37.54%
EBITDA Margin-87.81%
EBIT Margin-107.11%

Analyst Forecast

The average price target for Lumos Diagnostics Holdings Ltd. is AU$0.25, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetAU$0.25
Price Target Upside-21.88% Downside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast1.36%
EPS Growth Forecast39.13%

Scores

Smart Score5
AI Score―